ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NWBO Northwest Biotherapeutics Inc (QB)

0.561
-0.0465 (-7.65%)
Feb 21 2024 - Closed
Delayed by 15 minutes

Northwest Biotherapeutics (QB) Financial Summary

The current NWBO market cap is 647.31M. The company's latest EPS is USD -0.0910 and P/E is -1.87.

Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 412k2.41M1.29M1.01M1.68M
Operating Income -44.76M-27.46M-86.61M-52.7M-67.18M
Net Income -53.64M-20.3M-529.82M179.13M-105.03M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 24.67M9.13M32.9M40.16M31.32M
Total Liabilities 71.83M52.7M395.85M164.15M136.37M
Total Equity -47.16M-43.57M-362.95M-123.99M-128.1M

Cash Flow

Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -34.59M-31.86M-32.09M-38.3M-52.78M
Investing 45.4M-360k-8.14M-6.02M-2.9M
Financing 7.87M9.95M52.7M48.13M41.97M
Market Cap 647.31M
Price to Earnings Ratio -1.87
Price to Sales Ratio 113.33
Price to Cash Ratio 28.33
Price to Book Ratio -1.87
Dividend Yield -

Share Statistics

Shares Outstanding 1.15B
Average Volume (1 week) 1.25M
Average Volume (1 Month) 1.89M
52 Week Change -17.74%
52 Week High 1.11
52 Week Low 0.4001
Spread (Intraday) 0.01 (2.58%)

Company Info

Company Name Northwest Biotherapeutics Inc (QB)
Address 251 little falls drive
wilmington, delaware 19808
Website https://
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock